Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

This is the logo of the provider
64th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE 2026) 8 - 10 September 2026

Somapacitan in children and adolescents with Noonan syndrome: 2-year REAL8 results including switch from daily GH.

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Rare Endocrine Disorder
Congress oral presentation
Somapacitan